InteRNA Genomics Joins Applied Biosystems' SOLiD(TM) Software Community Program

BILTHOVEN, The Netherlands, July 22 /PRNewswire/ -- InteRNA Genomics B.V.
and Applied Biosystems Inc. announce signing of a Software Community
Commercial Membership Agreement regarding the exchange of InteRNA's
information and software tools related to Applied Biosystems' SOLiD(TM)
technology, InteRNA and Applied Biosystems will co-market InteRNA's small RNA
bioinformatics pipeline, miR-Intess(TM), for users of Applied Biosystems'
SOLiD(TM) System that enables massively parallel sequencing.
The Applied Biosystems SOLiD(TM) System is a revolutionary genetic
analysis platform that enables ultra-high-throughput (U-HTP) or massively
parallel sequencing (MPS) of clonally amplified DNA fragments linked to
beads. The sequencing methodology is based on sequential ligation with
dye-labeled oligonucleotides. The ultra-high-throughput capability and the
unmatched accuracy inherent in the SOLiD(TM) System, coupled with broad
application flexibility, provide a unique system for advancing genome
research and personalized genomics, where each individual can have its own
genome sequenced.
While the generation of MPS data can be outsourced to a number of
sequencing service providers, data processing and interpretation requires
highly skilled bioinformaticians and a dedicated computational infrastructure
- a challenge for many organizations. InteRNA Genomics delivers complete,
up-to-date and ready-to-interpret analyses of raw sequencing data, allowing
the researcher to focus on the biological problem at hand. The informatics
solutions are modular and easily customized, enabling development of data
analysis pipelines that take into account specifics of every individual
project.
The basic miR-Intess(TM) pipeline generates extensive tabular as well as
graphical output. Besides sample and sequencing statistics, comprehensive
data on known and candidate novel microRNAs (miRNAs) are provided, allowing
simultaneous digital expression profiling and small RNA discovery.
Furthermore, links to state-of-the-art miRNA target predictions and public
databases are provided. Customized solutions and pipeline extensions are
available on request.
"The participation of InteRNA Genomics in our SOLiD(TM) System software
community program is another concrete example of Applied Biosystems'
dedication to deliver new, cutting edge products and services to the next
generation sequencing community. Our goal is to provide our customers with
the best information and software tools available for the analysis of raw
data sets," said Roger Canales, Genetic Analysis Software Community Program
Manager at Applied Biosystems.
"We are very much honored to join Applied Biosystems' SOLiD(TM) System
software community program. This agreement further validates and confirms the
key benefits of our bioinformatics pipeline for the analysis of MPS data
sets," said Roel Schaapveld, Chief Operating Officer of InteRNA Genomics.
"Our expertise in small RNA analysis perfectly addresses the exponential gain
in attention for research into small regulatory RNA molecules and miRNAs in
particular."
About InteRNA Genomics B.V.
InteRNA Genomics B.V., a subsidiary of InteRNA Technologies B.V. and
based in Bilthoven, the Netherlands, offers services and software for
processing, analyzing and presenting ultra-high-throughput sequencing data
generated by various platforms. InteRNA's proprietary informatics solutions,
Intess(TM), convert large sets of raw sequencing data into interpretable
formats and integrate this information with existing proprietary and public
data resources.
InteRNA Genomics is co-founded by Aglaia Biomedical Ventures and Dr.
Eugene Berezikov and Dr. Edwin Cuppen, leading scientists in U-HTP data
generation and analysis. Berezikov and Cuppen pioneered the application of
high-throughput sequencing technologies for expression profiling and
discovery of small RNAs and miRNAs in particular, as described in several
high-profile papers.
More information on InteRNA can be accessed at
http://www.interna-genomics.com.
SOURCE InteRNA Genomics

Contact: Roel Q.J. Schaapveld, PhD, MBA, Chief Operating Officer, InteRNA
Genomics B.V., Phone: +31(0)30-229-6095/+31(0)6-290-88125, Email:
schaapveld@interna-genomics.com